Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.46 |
| ▸ | HRH3 known ✓ | Q9Y5N1 | 3/20 | 0.43 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL73482 | 0.97 | — | — | |
| Alcohol SCHEMBL29129752 | 0.86 | LOXL2 (0.46) | LOXL2HRH1CYP1A2CYP3A4CYP2D6 | |
| Formic Acid SCHEMBL8362262 | 0.84 | LOXL2 (0.45) | LOXL2HRH1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL1129624 | 0.83 | CYP17A1 (0.52) | LOXL2CYP3A4ALDH1A1HRH3 | |
| SCHEMBL842668 | 0.82 | HRH1 (0.56) | LOXL2HRH1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL842664 | 0.80 | HRH1 (0.59) | LOXL2HRH1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL151822 | 0.80 | LOXL2 (0.68) | LOXL2HRH1CYP1A2CYP3A4CYP2D6 | |
| Acetic Acid SCHEMBL29556933 | 0.80 | TSHR (0.41) | LOXL2ALDH1A1HSD17B10L3MBTL1 | |
| SCHEMBL272061 | 0.78 | HRH1 (0.63) | LOXL2HRH1CYP1A2CYP3A4CYP2D6 | |
| Hydrochloric Acid SCHEMBL1345387 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4626996-A1 | POLISHING COMPOSITIONS AND METHODS OF USE THEREOF | FUJIFILM Electronic Materials U.S.A, Inc. (US) | 2025-10-08 | — | — | EP | claimed |
| WO-2024118398-A1 | POLISHING COMPOSITIONS AND METHODS OF USE THEREOF | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2024-06-06 | — | — | WO | claimed |
| CN-115364236-A | Cell membrane anchored ROS (reactive oxygen species) -responsive chitosan gel prodrug system, preparation method and application thereof | 安徽工业大学 | 2022-11-22 | — | — | CN | claimed |
| US-20180082762-A1 | Transparent Conductive Film, Dispersion Liquid, Information Input Device, and Electronic Equipment | DEXERIALS CORPORATION (JP) | 2018-03-22 | — | — | US | claimed |
| CN-116180076-B | Environment-friendly process applied to filling through holes of wafers | 深圳创智芯联科技股份有限公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-116180076-A | Environment-friendly process applied to filling through holes of wafers | 深圳创智芯联科技股份有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-115477881-A | Water-based wear-resistant transparent antifogging resin polymer and preparation method thereof | 广东邦固化学科技有限公司 | 2022-12-16 | — | — | CN | disclosed |
| CN-115364236-A | Cell membrane anchored ROS (reactive oxygen species) -responsive chitosan gel prodrug system, preparation method and application thereof | 安徽工业大学 | 2022-11-22 | — | — | CN | disclosed |
| EP-3357917-A1 | ANDROGEN RECEPTOR MODULATORS AND USES THEREOF | Aragon Pharmaceuticals, Inc. (US) | 2018-08-08 | — | — | EP | disclosed |
| US-10023556-B2 | Androgen receptor modulators and uses thereof | ARAGON PHARMACEUTICALS, INC. (US) | 2018-07-17 | — | — | US | disclosed |
| US-9988535-B2 | Thiol group-containing colored compound, metal nanowire, dispersion liquid, transparent conductive film, information input device, and electronic apparatus | DEXERIALS CORPORATION (JP) | 2018-06-05 | — | — | US | disclosed |
| EP-3124481-B1 | ANDROGEN RECEPTOR MODULATORS AND USES THEREOF | ARAGON PHARMACEUTICALS INC (US) | 2018-03-28 | — | — | EP | disclosed |
| WO-2004108692-A1 | SULPHONAMIDE COMPOUNDS THAT MODULATE CHEMOKINE RECEPTOR ACTIVITY (CCR4) | ASTRAZENECA AB (SE) | 2004-12-16 | — | — | WO | disclosed |
| EP-0891223-B1 | METHODS FOR THE PREPARATION OF RESINS WITH LIGANDS ATTACHED THERETO THROUGH A LINKING GROUP COMPRISING SULFIDE, SULFOXIDE OR SULFONE FUNCTIONALITY | UNIV MASSEY (NZ) | 2004-10-20 | — | — | EP | disclosed |
| EP-1464391-A2 | Methods for the preparation of resins with ligands attached thereto through a linking group comprising sulfide, sulfoxide, sulfone or sulfonate functionality | MASSEY UNIVERSITY (NZ) | 2004-10-06 | — | — | EP | disclosed |
| WO-2004073030-A2 | METAL 8-HYDROXYQUINOLINE -FUNCTIONALIZED POLYMERS AND RELATED MATERIALS AND METHODS OF MAKING AND USING THE SAME | GEORGIA TECH RESEARCH CORPORATION (US) | 2004-08-26 | — | — | WO | disclosed |
| EP-0891223-A4 | METHODS FOR THE PREPARATION OF RESINS WITH LIGANDS ATTACHED THERETO THROUGH A LINKING GROUP COMPRISING SULFIDE, SULFOXIDE, SULFONE OR SULFONATE FUNCTIONALITY | UNIV MASSEY (NZ) | 1999-07-28 | — | — | EP | disclosed |
| EP-0891223-A1 | METHODS FOR THE PREPARATION OF RESINS WITH LIGANDS ATTACHED THERETO THROUGH A LINKING GROUP COMPRISING SULFIDE, SULFOXIDE, SULFONE OR SULFONATE FUNCTIONALITY | MASSEY UNIVERSITY (NZ) | 1999-01-20 | — | — | EP | disclosed |
| US-5789578-A | SUPPORTS WITH CHROMATOGRAPHIC RESINS WITH SULFIDE THAT CAN BE OXIDIZED | MASSEY UNIVERSITY (NZ) | 1998-08-04 | — | — | US | disclosed |
| WO-1997025139-A1 | METHODS FOR THE PREPARATION OF RESINS WITH LIGANDS ATTACHED THERETO THROUGH A LINKING GROUP COMPRISING SULFIDE, SULFOXIDE, SULFONE OR SULFONATE FUNCTIONALITY | MASSEY UNIVERSITY (NZ) | 1997-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10023556-B2 | Androgen receptor modulators and uses thereof | AR, ESRRA, NR5A1 | HRH1 2602/4885HRH3 3256/4885LOXL2 1485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.